Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer

Thi Oanh Tran, Luu Ho Thanh Lam, Nguyen Quoc Khanh Le

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Non-small cell lung cancer (NSCLC) is the most prevalent histological type of lung cancer and the leading cause of death globally. Patients with NSCLC have a poor prognosis for various factors, and a late diagnosis is one of them. The DNA methylation of CpG island sequences found in the promoter regions of tumor suppressor genes has recently received attention as a potential biomarker of human cancer. In this study, we report DNA methylation changes of the adenosine triphosphate (ATP)-binding cassette transporter G1 (ABCG1), which belongs to the ATP cassette transporter family in NSCLC patients. Our results demonstrate that ABCG1 is hyper-methylation in NSCLC samples, and these changes are negatively correlated to gene and protein expression. Furthermore, the expression of the ABCG1 gene is significantly associated with the survival time of lung adenocarcinoma (LUAD) patients; however, it did not show a correlation to overall survival (OS) of lung squamous cell carcinoma (LUSC) patients. Notably, we found ABCG1 methylation status at locus cg20214535 is strongly associated with the survival time and consistently observed hyper-methylation in LUAD samples. This novel finding suggests ABCG1 is a potential candidate for targeted therapy in lung cancer via this specific probe. In addition, we illustrate the protein–protein interaction (PPI) of ABCG1 with other proteins and the strong communication of ABCG1 with immune cells.

Original languageEnglish
Article number256
JournalFunctional and Integrative Genomics
Issue number3
Publication statusPublished - Sept 2023


  • ABCG1
  • Bioinformatics
  • DNA methylation
  • Epigenetics
  • Genomics analysis
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Genetics


Dive into the research topics of 'Hyper-methylation of ABCG1 as an epigenetics biomarker in non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this